MENU
+Compare
GRRMY
Stock ticker: OTC
AS OF
Oct 8 closing price
Price
$11.21
Change
+$0.31 (+2.84%)
Capitalization
1.03B

GRRMY Gerresheimer AG Forecast, Technical & Fundamental Analysis

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech... Show more

GRRMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for GRRMY with price predictions
Feb 03, 2026

GRRMY sees MACD Histogram just turned negative

GRRMY saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on January 29, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 17 instances where the indicator turned negative. In of the 17 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GRRMY as a result. In of 20 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

GRRMY moved below its 50-day moving average on January 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for GRRMY entered a downward trend on February 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for GRRMY crossed bullishly above the 50-day moving average on January 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 3 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.631) is normal, around the industry mean (11.448). P/E Ratio (37.690) is within average values for comparable stocks, (149.436). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.437). Dividend Yield (0.002) settles around the average of (0.017) among similar stocks. P/S Ratio (0.393) is also within normal values, averaging (111.001).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GRRMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GRRMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GRRMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

GRRMY paid dividends on June 25, 2025

Gerresheimer AG GRRMY Stock Dividends
А dividend of $0.01 per share was paid with a record date of June 25, 2025, and an ex-dividend date of June 09, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Klaus-Bungert-Strasse 4
Phone
+49 211618100
Employees
11660
Web
https://www.gerresheimer.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCSLX23.390.16
+0.69%
Victory Pioneer Global Equity C
JVAQX38.230.05
+0.13%
JPMorgan Value Advantage R4
BWLRX26.55-0.04
-0.15%
American Beacon Man Lg Cp Value R6
WBCCX9.84-0.03
-0.30%
TETON Westwood Balanced C
NQQQX45.66-0.73
-1.57%
Shelton Nasdaq-100 Index Institutional

Groups containing GRRMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRRMY
1D Price
Change %
GRRMY100%
N/A
Pharmaceuticals
category (380 stocks)
6%
Poorly correlated
-0.29%
Pharmaceuticals: Other
category (107 stocks)
5%
Poorly correlated
+0.00%